Trials / Conditions / Idiopathic Myelofibrosis
Idiopathic Myelofibrosis
7 registered clinical trials studyying Idiopathic Myelofibrosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People NCT07362225 | MPN Research Foundation | — |
| Terminated | A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors NCT02440685 | Asana BioSciences | Phase 1 / Phase 2 |
| Completed | Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential NCT01433445 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Familial Myeloproliferative Disorders NCT00666289 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Research Tissue Bank NCT00666549 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Correlative Biomarker Study in Patients With Myeloproliferative Disorders NCT00665067 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders NCT00433862 | National Institutes of Health Clinical Center (CC) | — |